About Nymbl Science
Nymbl Science is a company based in London (United Kingdom) founded in 2014. Nymbl Science has raised $24.61 million across 7 funding rounds from investors including Cobalt Ventures, Outcomes Collective and 450 Ventures. Nymbl Science operates in a competitive market with competitors including FallCall Solution, GaitBetter, Mynd Immersive, Chequi and Verso Vision, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nymbl Science Ltd.
- Date of Incorporation 18 Jul, 2014
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.61 M (USD)
in 7 rounds
-
Latest Funding Round
$984.06 K (USD), Series B
Aug 29, 2025
-
Investors
Cobalt Ventures
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nymbl Science
Unlock access to complete
Unlock access to complete
Funding Insights of Nymbl Science
Nymbl Science has successfully raised a total of $24.61M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $984.06 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nymbl Science
Nymbl Science has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Cobalt Ventures, Outcomes Collective and 450 Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on buyouts and equity investments in the healthcare sector
|
Locked | Locked | Locked | |
|
Private equity investments are targeted at healthcare and education sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Nymbl Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nymbl Science
Investment portfolio details for Nymbl Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nymbl Science
Detailed financials for Nymbl Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nymbl Science Comparisons
Peer comparison for Nymbl Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nymbl Science
Nymbl Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FallCall Solution, GaitBetter, Mynd Immersive, Chequi and Verso Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Telemonitoring software for elderly and caregivers is developed.
|
|
| Locked | Locked | Locked |
VR-based treadmill for elderly care
|
|
| Locked | Locked | Locked |
Delivers VR therapy to enhance quality of life for older adults in healthcare settings.
|
|
| Locked | Locked | Locked |
Personal safety app and tracker for emergency alerts and health monitoring.
|
|
| Locked | Locked | Locked |
AI system detects and prevents falls by alerting staff in care facilities.
|
Detailed competitors of Nymbl Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nymbl Science
Complete news archive for Nymbl Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nymbl Science
Nymbl Science was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Nymbl Science is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Nymbl Science is a funded company, having raised a total of $24.61M across 7 funding rounds to date.
Nymbl Science is engaged in activities related to science or technology. Specific details about sectors, solutions, or services are not provided on the website. The scope of operations remains unclear due to limited content.
Nymbl Science's top competitors include GaitBetter, FallCall Solution and Mynd Immersive.
Nymbl Science has 5 investors. Key investors include Cobalt Ventures, Outcomes Collective, 450 Ventures, Boomtown Accelerators, and Rockies Venture Fund.